---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-077920"
form_type: "8-K"
ticker: "HYPD"
cik: "0001682639"
company_name: "HYPERION DEFI, INC."
filed_at: "2022-07-07T23:59:59+00:00"
generated_at: "2026-06-24T19:43:35.353356+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Eyenovia appoints Drs. Strahlman and Palanki as independent directors, board expands to 8 seats

## Summary
- Both appointments effective July 1, 2022; board increases from 6 to 8 members.
- Dr. Strahlman, former EVP R&D at BD and ex-CMO at GSK, joins audit and compensation committees.
- Dr. Palanki, EVP Commercial Strategy at REGENXBIO with Santen/Genentech background, joins compensation committee.
- Both directors determined independent under SEC and Nasdaq rules.

## SEC filing metadata
- accession: 0001104659-22-077920
- form_type: 8-K
- ticker: HYPD
- cik: 0001682639
- company_name: HYPERION DEFI, INC.
- filed_at: 2022-07-07T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682639/000110465922077920/0001104659-22-077920-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682639/000110465922077920/tm2220584d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-077920
- JSON: https://secwatch.observer/filing/0001104659-22-077920.json
- Plain text: https://secwatch.observer/filing/0001104659-22-077920.txt

## Key facts
- Executive change
  Dr. Ellen R. Strahlman was appointed as Director at HYPERION DEFI, INC..
  - Action: appointed
  - Role: Director
  source text: On July 1, 2022, the Board of Directors (the “Board”) of Eyenovia, Inc. (the “Company”) appointed Dr. Ellen R. Strahlman and Dr. Ram Palanki as members of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682639/000110465922077920/0001104659-22-077920-index.htm
- Executive change
  Dr. Ram Palanki was appointed as Director at HYPERION DEFI, INC..
  - Action: appointed
  - Role: Director
  source text: On July 1, 2022, the Board of Directors (the “Board”) of Eyenovia, Inc. (the “Company”) appointed Dr. Ellen R. Strahlman and Dr. Ram Palanki as members of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682639/000110465922077920/0001104659-22-077920-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.